⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1644988 | 1.00 | — | — | |
| SCHEMBL4774239 | 1.00 | — | — | |
| SCHEMBL16454010 | 0.92 | — | — | |
| SCHEMBL7625313 | 0.92 | — | — | |
| SCHEMBL9024964 | 0.92 | — | — | |
| SCHEMBL27965922 | 0.91 | CHRNB2 (0.31) | — | |
| SCHEMBL21900849 | 0.90 | CYP1A2 (0.41) | — | |
| SCHEMBL23747471 | 0.83 | — | — | |
| SCHEMBL28149301 | 0.83 | — | — | |
| SCHEMBL29290533 | 0.80 | KDM4E (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022257833-A1 | INTERMEDIATE OF SUBSTITUTED PHENYLPROPYL PYRIDINE DERIVATIVE AND PREPARATION METHOD FOR INTERMEDIATE | 上海海雁医药科技有限公司 | 2022-12-15 | — | — | WO | disclosed |
| CN-104725397-A | Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them | SERVIER LAB | 2015-06-24 | — | — | CN | disclosed |
| US-20150045367-A1 | CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 | PHARMACYCLICS LLC | 2015-02-12 | — | — | US | disclosed |
| CN-102933574-B | Pharmaceutically acceptable salts of (e)-n-(4-((3-chloro-4-(2-pyridyl methoxy) phenyl) amino)-3-cyano-7-ethyoxyl-6-quinolyl)-3-((2r)-1-methyl pyrrolidine-2-propyl)-2-acrylamide, preparation method and application of salts in medicines | SHANGHAI HENGRUI PHARMACEUTICAL CO.,LTD. (CN) | 2014-10-01 | — | — | CN | disclosed |
| CN-102471312-B | 6-aminoquinazoline or 3-cyanoquinoline derivatives, preparation method and medical application thereof | JIANGSU HENGRUI MEDICINE CO | 2014-06-18 | — | — | CN | disclosed |
| CN-102675287-A | Pharmaceutically acceptable salts of (E)-N-(4-((3-chloro-4-(2-pyridyl methoxy) phenyl) amino)-3-cyano-7-ethyoxyl-6-quinolyl)-3-((2R)-1-methyl pyrrolidine-2-propyl)-2-acrylamide, preparation method and application of salts in medicines | JIANGSU HENGRUI MEDICINE CO | 2012-09-19 | — | — | CN | disclosed |
| US-8188089-B2 | Tylophorine analogs as antitumor agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-05-29 | — | — | US | disclosed |
| US-7700634-B2 | (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor | N.V. ORGANON (NL) | 2010-04-20 | — | — | US | disclosed |
| US-20080300254-A1 | Tylophorine Analogs as Antitumor Agents | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-12-04 | — | — | US | disclosed |
| US-20070142446-A1 | (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor | MERCK SHARP & DOHME B.V. (NL) | 2007-06-21 | — | — | US | disclosed |
| EP-1725232-A1 | (INDOL-3-YL)-HETEROCYCLE DERIVATIVES AS AGONISTS OF THE CANNABINOID CB1 RECEPTOR | N.V. Organon (NL) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005089754-A1 | (INDOL-3-YL)-HETEROCYCLE DERIVATIVES AS AGONISTS OF THE CANNABINOID CB1 RECEPTOR | AKZO NOBEL N.V. (NL) | 2005-09-29 | — | — | WO | disclosed |